Chapter 28 – Assessment of Case Reports and Clinical Series

[1]  G. Koren,et al.  Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.

[2]  K. Jones,et al.  Birth outcomes in pregnant women taking fluoxetine. , 1996, The New England journal of medicine.

[3]  A. Gosch,et al.  Social-emotional and behavioral adjustment in children with Williams-Beuren syndrome. , 1994, American journal of medical genetics.

[4]  H. Steinhausen,et al.  The fetal alcohol syndrome in adolescence , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[5]  L. Wilkins-Haug,et al.  Toluene embryopathy: clinical delineation and developmental follow-up. , 1994, Pediatrics.

[6]  H. Steinhausen,et al.  Prenatal alcohol exposure and long-term developmental consequences , 1993, The Lancet.

[7]  J. Clayton-Smith,et al.  Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. , 1993, American journal of medical genetics.

[8]  R W Smithells,et al.  Recognition of thalidomide defects. , 1992, Journal of medical genetics.

[9]  A. Scialli.  A Clinical Guide to Reproductive and Developmental Toxicology , 1991 .

[10]  S. Rutter,et al.  PSYCHOLOGICAL CHARACTERISTICS OF SOTOS SYNDROME , 1991, Developmental medicine and child neurology.

[11]  R. Sokol,et al.  Fetal alcohol exposure and adverse pregnancy outcomes. , 1991, Contributions to gynecology and obstetrics.

[12]  H. Tilson,et al.  Polychlorinated biphenyls and the developing nervous system: cross-species comparisons. , 1990, Neurotoxicology and teratology.

[13]  K. Jones,et al.  Pattern of malformations in the children of women treated with carbamazepine during pregnancy. , 1989, The New England journal of medicine.

[14]  S. Soukup,et al.  Fragile X syndrome: recognition in young children. , 1989, Pediatrics.

[15]  H B Newcombe,et al.  Genetic disorders in children and young adults: a population study. , 1988, American journal of human genetics.

[16]  L. Greenswag,et al.  ADULTS WITH PRADER‐WILLI SYNDROME: A SURVEY OF 232 CASES , 1987 .

[17]  R. Brent.  Evaluating the alleged teratogenicity of environmental agents. , 1986, Clinics in perinatology.

[18]  C. Newman.  The thalidomide syndrome: risks of exposure and spectrum of malformations. , 1986, Clinics in perinatology.

[19]  James W. Hanson.  Teratogen update: fetal hydantoin effects. , 1986, Teratology.

[20]  A. Wilk,et al.  Teratogen update: vitamin A congeners. , 1986, Teratology.

[21]  Frank A. Bisby,et al.  Taxonomic Analysis in Biology: Computers, Models, and Databases , 1985 .

[22]  P. Fernhoff,et al.  Retinoic acid embryopathy. , 1985, The New England journal of medicine.

[23]  R. W. Miller.  Congenital PCB poisoning: a reevaluation. , 1985, Environmental health perspectives.

[24]  S. Hsu,et al.  Discovery and epidemiology of PCB poisoning in Taiwan: a four-year followup. , 1985, Environmental health perspectives.

[25]  C. Curry,et al.  The fetal valproate syndrome. , 1984, American journal of medical genetics.

[26]  Paul Turner.  Drugs and pregnancy: human teratogenesis and related problems. , 1983, Archives of Disease in Childhood.

[27]  FranzW. Rosa,et al.  TERATOGENICITY OF ISOTRETINOIN , 1983, The Lancet.

[28]  W. Nyhan,et al.  Lesch‐Nyhan Disease: Clinical Experience with Nineteen Patients , 1982 .

[29]  J. Warkany.  Aminopterin and methotrexate: folic acid deficiency. , 1978, Teratology.

[30]  T. Clarkson,et al.  Intra-uterine methylmercury poisoning in Iraq. , 1974, Pediatrics.

[31]  T. Shepard.  Catalog of Teratogenic Agents , 1973 .

[32]  Peter H. A. Sneath,et al.  Numerical Taxonomy: The Principles and Practice of Numerical Classification , 1973 .

[33]  K. Ehlers,et al.  Trimethadione and human teratogenesis. , 1970, Teratology.

[34]  D. Rimoin.  Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics , 1997 .

[35]  A. Streissguth,et al.  Pattern of Malformation in Offspring of Chronic Alcoholic Mothers , 1995, Alcohol health and research world.

[36]  E. Krug,et al.  Purine and Pyrimidine Metabolism , 1995 .

[37]  G. Niccols.  Fetal alcohol syndrome: Implications for psychologists☆ , 1994 .

[38]  A. Streissguth.  2 – Fetal Alcohol Syndrome and Fetal Alcohol Effects: A Clinical Perspective of Later Developmental Consequences , 1992 .

[39]  R. Pauli,et al.  Maternal and fetal sequelae of anticoagulation during pregnancy. , 1980, The American journal of medicine.

[40]  J. Warkany.  Warfarin embryopathy. , 1976, Teratology.